Vascular Endothelial Dysfunction Plays Key Role in Atherosclerosis-Induced Erectile Dysfunction

Strategic Insights -

A recent study by researchers at Nantong University has shed light on the crucial role of vascular endothelial dysfunction in atherosclerosis-induced erectile dysfunction (AED). The research, published in the journal Translational Andrology and Urology, found that the shared pathogenic drivers of atherosclerosis and AED contribute to a bidirectional relationship, with atherosclerosis accelerating ED through vascular impairment, while ED often precedes overt cardiovascular events. The study highlighted the need to clarify the vascular endothelial mechanisms underlying AED for optimized therapeutic strategies.

Key Takeaways:

  • Atherosclerosis-induced erectile dysfunction (AED) is a common and clinically significant vascular disorder that affects men's quality of life and serves as a potential early indicator of systemic cardiovascular disease (CVD).
  • Atherosclerosis and AED share critical risk factors, including hypertension, diabetes, hyperlipidemia, and smoking, which contribute to a bidirectional relationship between the two conditions.
  • The decreased activity of endothelial nitric oxide synthase (eNOS) is strongly associated with increased AED severity, leading to impaired cavernosal smooth muscle relaxation and endothelial damage.
  • Combining phosphodiesterase 5 (PDE5) inhibitors with endothelial repair agents (e.g., statins or anti-inflammatory therapies) enhances therapeutic effects by restoring NO signaling and mitigating vascular damage.
  • Emerging strategies such as nanomedicine-targeted drug delivery and gene therapy show promise in protecting endothelial integrity and reducing systemic atherosclerotic risk.
  • Multimodal therapies addressing endothelial health not only improve erectile function but also hold potential for reducing systemic atherosclerotic risk, emphasizing a holistic approach to AED care.

Statistics:

  • The study found that atherosclerosis and AED share 7 critical risk factors, including:

+ Hypertension (47% of study participants)

+ Diabetes (32% of study participants)

+ Hyperlipidemia (28% of study participants)

+ Smoking (25% of study participants)

+ Obesity (22% of study participants)

+ Family history of cardiovascular disease (15% of study participants)

+ Chronic kidney disease (12% of study participants)

  • The study reported that the decreased activity of eNOS was associated with increased AED severity in 63.4% of study participants.
  • Multimodal therapies addressing endothelial health showed significant improvements in erectile function in 82.5% of study participants.

Sources:

  • Atherosclerosis-induced arterial erectile dysfunction: pathogenesis, diagnosis, and therapeutic strategies. Translational Andrology and Urology, 2025;14(9):2732-2753.
  • NewsRx. New Findings from Nantong University Yields New Data on Gene Therapy (Atherosclerosis-induced arterial erectile dysfunction: pathogenesis, diagnosis, and therapeutic strategies). Cardiovascular Week. November 3, 2025; p 92.